Xanadu Quantum Technologies shares rose after the company announced a multi-million-dollar partnership with Bluefors to develop cryogenic infrastructure for utility-scale quantum computing data centers. The collaboration targets a high-performance prototype designed to eliminate traditional industrial-scale cryoplants, with future work focused on a mass-manufacturable cryogenic module for single-photon detectors. The companies aim to create a blueprint for Xanadu's planned quantum data center and other utility-scale facilities. Separately, RBC Capital initiated coverage of Xanadu with an Outperform rating and a $16 price target. Xanadu shares were up 5.66% at $5.03 at publication, according to Benzinga Pro data.